BioElectronics Corporation (BIEL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Aug 1, 2025, 3:17 PM EDT
Avangrid Market Cap
BioElectronics has a market cap or net worth of $4.94 million as of August 1, 2025. Its market cap has increased by 100.00% in one year.
Market Cap
4.94M
Enterprise Value
n/a
Revenue
1.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 14, 2005, BioElectronics's market cap has decreased from 25.38M to 4.94M, a decrease of -80.53%. That is a compound annual growth rate of -7.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 4.94M | - |
| Dec 31, 2024 | 4.94M | - |
| Dec 29, 2023 | 4.94M | -60.00% |
| Dec 30, 2022 | 12.35M | -51.74% |
| Dec 31, 2021 | 25.60M | -18.41% |
| Dec 31, 2020 | 31.38M | 71.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |